Australia Stock Alert

AUSTR

CLOSING UPDATE: CSL in 6th consecutive fall, nears five-month low July 21, 2017 16:00:00 AEST

NEWS BITES - AUSTRALIA

This is an end of day Alert, produced after today's Australian market close. It concludes the BSS News Bites intra-day Alert series (summaries below).

CSL, Australia's largest pharmaceuticals & biotechnology company by market capitalisation, slipped further on Friday, sliding an additional 60.0c (or 0.5%) to trade at $A126.79. The stock decreased 0.29% on Wednesday and 0.47% on Thursday bringing its 6-day fall to 4.5%. It is now approaching its 109-day low of $A125.16. Compared with the All Ordinaries Index which fell 34.5 points (or 0.6%) in the day, this represented a relative price increase of 0.1%.

TODAY'S ALERTS

Afternoon Alert: CSL in 6th consecutive fall, nears five-month low

July 21, 2017 13:00:00 AEST

CSL Limited (ASX:CSL) slipped further on Friday, sliding an additional 17.0c (or 0.1%) to trade at $A127.22. The stock decreased 0.29% on Wednesday and 0.47% on Thursday bringing its 6-day fall to 4.2%. It is now approaching its 99-day low of $A125.16.

Morning Alert: CSL keeps sliding: down 5.5% in 6 days

July 21, 2017 11:00:00 AEST

CSL Limited (ASX:CSL) extended its slide on Friday, shedding an additional $A1.89 (or 1.5%) to trade at $A125.50.

RECENT ALERTS

CLOSING UPDATE: CSL decreased further 0.3%, led Pharmaceuticals & biotechnology sector lower

July 20, 2017 16:00:00 AEST

CSL, Australia's largest pharmaceuticals & biotechnology company by market capitalisation, has decreased 0.5% to trade at $A127.39 vs. the Pharmaceuticals & biotechnology sector which weakened 63.1 points (or 0.4%) to 15,962.9. Representing a weighting of about 86.9% of the sector, the stock accounted for the loss. Compared with the All Ordinaries Index which rose 26.3 points (or 0.5%) in the day, this represented a relative price change of -0.9%.

Afternoon Alert: CSL decreases 0.2%, leads Pharmaceuticals & biotechnology sector lower

July 20, 2017 13:00:00 AEST

CSL Limited (ASX:CSL) has decreased 0.2% to trade at $A127.73 vs. the Pharmaceuticals & biotechnology sector which weakened 20.4 points (or 0.1%) to 16,005.6. Representing a weighting of about 86.9% of the sector, the stock accounted for the loss. The shares have underperformed 81% of the market in the past week.

CSL Limited (AU:CSL; ASX:CSL; AX:CSL)

ISIN: AU000000CSL8

PermID: 4295856855

Source: www.BuySellSignals.com